- $4.81m
- $8.40m
- AU$0.17m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
NASDAQ RESUMED AT 11:23 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:18 AM
NASDAQ RESUMED AT 11:17 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:12 AM
Brief: Gelteq Commences Veterinary Medicine Clinical Trial To Support An FDA Regulatory Pathway
Brief: Gelteq Announces USD $3.5 Million Strategic Debt Financing To Accelerate Commercialization And Support Revenue Growth
Brief: Gelteq And Healthy Extracts To Expand Gel-Based Nutrition Technologies With New Strategic Manufacturing & Commercial Partnership
Brief: Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
Brief: Gelteq Furthers Asia Presence With Hong Kong Flag Football Program
Brief: Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market
IDT Australia rises on MoU with US-based drug-delivery platform
Brief: IDT Australia Says Co Signs Agreement For Manufacturing Facility
Brief: Gelteq Expands US Operations With Healthy Extracts As North American Fulfillment Partner
Brief: Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC
Brief: Gelteq's Healthy Extracts Increases Initial Order By 50% To Meet Growing Market Demand
Brief: Gelteq Limited Announces Closing of US$5.2 Mln IPO
Brief: Gelteq Limited Prices IPO Of 1.3 Mln Shares At $4.00 Each
Brief: Gelteq Ltd Says The Benchmark Company, Llc Is Now The Underwriter Of U.S. IPO- SEC Filing